Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

BACKGROUND: Obesity is an independent adverse prognostic factor in early breast cancer patients, but it is still controversial whether obesity may affect adjuvant endocrine therapy efficacy. The aim of our study (ancillary to the two clinical trials Gruppo Italiano Mammella (GIM)4 and GIM5) was to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sini, V, Lunardi, G, Cirillo, M, Turazza, M, Bighin, C, Giraudi, S, Levaggi, A, Piccioli, P, Bisagni, G, Gnoni, R, Stridi, G, Porpiglia, M, Picardo, E, Ponzone, R, Marenco, D, Mansutti, M, Puglisi, F, Del Mastro, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950872/
https://www.ncbi.nlm.nih.gov/pubmed/24448359
http://dx.doi.org/10.1038/bjc.2014.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950872/
https://www.ncbi.nlm.nih.gov/pubmed/24448359
http://dx.doi.org/10.1038/bjc.2014.2

Ejemplares similares